MiMedx Group Inc (MDXG) exhibits 82.6% gross margins and 47.2% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 6.7x enterprise multiple and 4.8% implied options volatility.
Sustained 82.6% gross profitability converts into 15.3% operating margin and 47.2% ROIC, outpacing sector cost of capital.
ROIC: 47.2% // GM: 82.6%YoY revenue trajectory of +20.0% paired with 12.77% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +20.0% // FCF YLD: 12.77%Altman Z-Score of 6.45 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 6.45 // F-SCORE: 9/9Trading at 11.9x trailing P/E (10.0x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 11.9x // EV/EBITDA: 6.7xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $3.97 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 11.6% net margins.
NET MARGIN: 11.6% // D/E: 0.06x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for MDXG & activate live FRED threshold breach alerts.